Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 14,125 shares at $124.39 ($1.7M) on 2013-11-04, disclosed to the SEC on 2013-11-05.
Scheduled sale ($1.7M) by EVP, Chief Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.82 | 12,886 | $1.6M | 91.2% |
| 2 | $124.39 | 1,239 | $154K | 8.8% |
| Total | $123.87 avg | 14,125 | $1.7M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |